Tag: seizure treatment


DEPAKOTE

Overview of Depakote and Valproic Acid Depakote, a pharmacological agent known generically as valproic acid, represents a significant advancement in the dual fields of neurology and psychiatry. Originally developed as an anticonvulsant, its utility has expanded over decades to become a foundational treatment for a variety of conditions characterized by neuronal hyperexcitability and mood dysregulation. […]

Read More

FELBAMATE

FELBAMATE: An Overview on its Therapeutic Use and Clinical Implications Felbamate (FBM) is an antiepileptic drug used in the treatment of partial or secondarily generalized seizures in patients with Lennox-Gastaut syndrome (LGS). It is also used for the treatment of partial seizures in adults. FBM is an effective drug, yet its use is limited by […]

Read More

ZARONTIN

Introduction to Zarontin (Ethosuximide) Zarontin, the brand name for the pharmaceutical compound ethosuximide, stands as a cornerstone in the pharmacological management of pediatric epilepsy. Classified definitively as an anticonvulsant, this medication is specifically indicated for the control and prevention of absence seizures, also historically referred to as petit mal seizures. These seizures are characterized by […]

Read More

TEMPORAL LOBECTOMY

Temporal Lobectomy: Definition and Scope Temporal lobectomy is a major neurosurgical procedure defined by the partial or complete removal of the temporal lobe of the brain. This intervention is primarily utilized as a therapeutic option for patients suffering from severe, drug-resistant neurological disorders, most notably intractable epilepsy originating within the temporal lobe structures. The procedure […]

Read More

PRIMIDONE

Introduction and Nomenclature Primidone, most widely recognized by its generic name, is an established anti-epileptic drug (AED) that has been utilized in clinical settings for decades. It is marketed under the trade name Mysoline in many jurisdictions. Chemically, Primidone is classified as a desoxybarbiturate, a structural analog closely related to the traditional barbiturate class, which […]

Read More

ELECTROCONVULSIVE THERAPY (ECT)

Introduction to Electroconvulsive Therapy (ECT) Electroconvulsive Therapy (ECT) is a highly specialized medical procedure used primarily in psychiatry, defined by the intentional induction of a generalized seizure through the application of a brief electrical stimulus to the patient’s scalp. Despite its long history and demonstrable clinical effectiveness for specific, severe mental health conditions, ECT remains […]

Read More

PENTOBARBITAL

Definition and Classification of Pentobarbital Pentobarbital, chemically identified as a barbiturate derivative, is classified primarily as a short- to intermediate-acting central nervous system (CNS) depressant. Historically, its pharmacological profile established it as a foundational drug within the medical arsenal used for managing anxiety, inducing sedation, and promoting sleep. The drug acts upon the CNS to […]

Read More

ACETYLUREAS

Introduction to Acetylureas: Classification and Definition The class of pharmaceuticals known as acetylureas constitutes a significant, though specialized, category within the broader group of central nervous system (CNS) agents, primarily utilized as antiepileptic drugs (AEDs). These compounds are chemically defined by their intrinsic structural similarity to the hydantoins, a relationship critical to understanding both their […]

Read More

EPILEPSY SURGERY

Epilepsy Surgery: A Comprehensive Review Introduction and Core Definition Epilepsy is a chronic, non-communicable neurological disorder characterized by recurrent, unprovoked seizures, which are transient occurrences of signs and symptoms due to abnormal, excessive, or synchronous neuronal activity in the brain. While pharmacological treatments—specifically anti-epileptic drugs (AEDs)—are the primary and highly successful initial line of defense, […]

Read More